Assenagon Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.43M | Buy |
|
|||||
|
2025
Q2 | $1.73M | Buy |
|
|||||
|
2025
Q1 | $749K | Sell |
|
|||||
|
2024
Q4 | $2.25M | Sell |
|
|||||
|
2024
Q3 | $4.58M | Sell |
|
|||||
|
2024
Q2 | $6.13M | Buy |
|
|||||
|
2024
Q1 | $4.22M | Buy |
|
|||||
|
2023
Q4 | $2.54M | Sell |
|
|||||
|
2023
Q3 | $4.43M | Buy |
|
|||||
|
2023
Q2 | $5.14M | Buy |
|
|||||
|
2023
Q1 | $2.58M | Buy |
|
|||||
|
2022
Q4 | $1.33M | Buy |
|
|||||
|
2022
Q3 | $236K | Sell |
|
|||||
|
2022
Q2 | $802K | Buy |
|
|||||
|
2022
Q1 | $1.09M | Buy |
|
|||||
|
2021
Q4 | $862K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $552K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $6.08M | Buy |
|